| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
5 companies
Bienaime Jean Jacques is a Director at BIOMARIN PHARMACEUTICAL INC with holdings across 5 companies. Recent SEC Form 4 filings include 8 buys and 6 sells.
Estimated insider holdings value: $28.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | IMNM Immunome, Inc. | Director | Buy | 2,000 | $21.84 | $43,670.00 | +2.7% | - | - | |
| Mar 9, 2026 | KROS Keros Therapeutics, Inc. | Director | Buy | 2,000 | $11.21 | $22,420.00 | +36.7% | - | - | |
| Jun 3, 2025 | IMNM Immunome Inc. | Director | Buy | 5,000 | $9.38 | $46,900.00 | +15.9% | +0.2% | - | |
| Mar 25, 2025 | IMNM Immunome Inc. | Director | Buy | 7,800 | $7.78 | $60,684.00 | +33.0% | +25.8% | +192.1% | |
| Mar 24, 2025 | IMNM Immunome Inc. | Director | Buy | 7,000 | $8.21 | $57,470.00 | +42.1% | +7.2% | +148.0% | |
| Aug 16, 2024 | IMNM Immunome Inc. | Director | Buy | 7,000 | $13.94 | $97,608.00 | +72.8% | -17.7% | -24.0% | |
| May 21, 2024 | IMNM Immunome Inc. | Director | Buy | 2,000 | $13.57 | $27,139.80 | +26.3% | +4.8% | -42.0% | |
| May 10, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 40,000 | $81.38 | $3,255,200.00 | -4.0% | +8.5% | -27.4% | |
| Apr 12, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 40,000 | $91.13 | $3,645,000.00 | -4.0% | -9.0% | -38.4% | |
| Mar 6, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 2,000 | $86.11 | $172,223.00 | -0.2% | -8.9% | -17.9% |